CHICAGO, June 25 (Reuters) - The U.S. Centers for Disease Control and Prevention said on Thursday it plans to reinstate booster shoots of a vaccine that protects babies and toddlers against bacterial meningitis.
The CDC said in a statement it believes manufacturers will have enough supply of the vaccine to resume giving a booster shot of HiB (Haemophilus influenza type b) to children aged 12 to 15 months.
Merck & Co Inc (MRK.N) in 2007 recalled its HiB vaccines because production equipment may not have been properly sterilized. The CDC said HiB vaccine made by Sanofi Pasteur, the vaccines division of Sanofi-Aventis (SASY.PA), will increase enough starting in July to allow reinstatement of the HiB booster for children aged 12 to 15 months.
Short supplies of the vaccine will not allow a mass recall of older children who missed their booster, CDC said.
Reporting by Julie Steenhuysen; Editing by Bill Trott